Inventor · disambiguated record
Julie Mcearchern
Also filed as: MCEARCHERN JULIE · MCEARCHERN JULIE A · MCEARCHERN JULIE ANNA
13 granted patents·3 pending applications·344 citations·filing 2004–2023
94Inventor score
Files withSEATTLE GENETICS INC6LAW CHE-LEUNG5MCDONAGH CHARLOTTE2LEWIS TIMOTHY S1NORTHWEST BIOTHERAPEUTICS INC1
Top patents by PatentIndex Score
16 records- 0197US8067546B2Humanized anti-CD70 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2006·Granted Nov 29, 2011·71 cites·25 claims
- 0297US7491390B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2005·Granted Feb 17, 2009·60 cites·28 claims
- 0396US8337838B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersLAW CHE-LEUNG·Filed 2009·Granted Dec 25, 2012·30 cites·28 claims
- 0495US8663642B2Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disordersLAW CHE-LEUNG·Filed 2010·Granted Mar 4, 2014·44 cites·21 claims
- 0595US8562987B2Humanized anti-CD70 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2011·Granted Oct 22, 2013·27 cites·24 claims
- 0695US7641903B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2007·Granted Jan 5, 2010·45 cites·22 claims
- 0793US9051372B2Anti-CD70 antibody and its use for the treatment of cancer and immune disordersLAW CHE-LEUNG·Filed 2008·Granted Jun 9, 2015·24 cites·12 claims
- 0893US8647624B2Treatment of immune disorders with anti-CD70 antibodyLAW CHE-LEUNG·Filed 2008·Granted Feb 11, 2014·21 cites·20 claims
- 0985US10201615B2Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathwaySEATTLE GENETICS INC·Filed 2016·Granted Feb 12, 2019·4 cites·21 claims
- 1083US12496353B2Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathwaySEAGEN INC·Filed 2023·Granted Dec 16, 2025·0 cites·13 claims
- 1183US9272052B2Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathwayLEWIS TIMOTHY S·Filed 2011·Granted Mar 1, 2016·8 cites·2 claims
- 1277US11607460B2Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathwaySEATTLE GENETICS INC·Filed 2018·Granted Mar 21, 2023·1 cites·12 claims
- 1372US7790039B2Tangential flow filtration devices and methods for stem cell enrichmentNORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Granted Sep 7, 2010·9 cites·27 claims
- 1464US2008025989A1Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersSEATTLE GENETICS INC·Filed 2007·Application pending·0 cites
- 1562US2010129362A1Treatment of psoriatic arthritis with anti-cd70 antibodySEATTLE GENETICS INC·Filed 2009·Application pending·0 cites
- 1644US2012294863A1Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune DisordersLAW CHE-LEUNG·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →